Cover
Cover | Dec. 08, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 8, 2021 |
Entity File Number | 001-39069 |
Entity Registrant Name | Aprea Therapeutics, Inc. |
Entity Central Index Key | 0001781983 |
Entity Tax Identification Number | 84-2246769 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 535 Boylston Street |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02116 |
City Area Code | 617 |
Local Phone Number | 463-9385 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.001 per share |
Trading Symbol | APRE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |